请输入您要查询的百科知识:

 

词条 Medication discontinuation
释义

  1. End-of-life care

  2. Effects

  3. See also

  4. References

{{short description|Ceasing of a medication treatement for a patient}}{{redirect|Discontinuation|the discontinuation of products|End-of-life (product)}}Medication discontinuation is the ceasing of a medication treatment for a patient by either the clinician or the patient themself.[1][2] When initiated by the clinician, it is known as deprescribing.[3] Medication discontinuation is an important medical practice that may be motivated by a number of reasons:[3][4]
  • Reducing polypharmacy
  • Reducing health expenditure
  • Improving quality of life by ceasing medications with potential adverse effects or where the indication for a medical treatment may have changed
  • Reflect changes in evidence that support a treatment
  • Reflecting changes in treatment goals, such as a move to end-of-life care.[5]

Unlike the prescribing of medications, appropriate discontinuation has not attracted nearly as much attention or interest.[6]

End-of-life care

Medications may be stopped in the context of end-of-life care, such as medications that may affect risk factors for future disease. Medications that may be stopped as part of discussions about end-of-life care include antihypertensives, medications for diabetes, and drugs for high cholesterol.[5]

Effects

Drug discontinuation may cause rebound effects (return of the symptoms the drug relieved, and that, to a degree stronger than they were before treatment first began) and withdrawal syndromes (symptoms caused by the discontinuation by the drug itself).

Drug discontinuation may be difficult to adjust to, owing to the long term use and the symbolism associated with ceasing medications, such as the decision to stop chemotherapy.[5]

Recent research (Nixon & Vendelø, 2016) shows that General Practitioners (GPs) who actively consider discontinuation, are reluctant to do so, as they experience that the safest decision is to continue prescriptions, rather than discontinue them. In part this is due to the ambiguity about the appropriateness of discontinuing medication. The clinical guidelines available to GPs do not encourage discontinuation of medication, and thus, they offer GPs a weak frame for discontinuation.

See also

  • Deprescribing
  • Withdrawal syndrome
  • Antidepressant discontinuation syndrome

References

1. ^{{cite journal|last1=Raebel|first1=Marsha A.|last2=Schmittdiel|first2=Julie|last3=Karter|first3=Andrew J.|last4=Konieczny|first4=Jennifer L.|last5=Steiner|first5=John F.|title=Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research employing Electronic Databases|journal=Medical Care|volume=51|issue=8 0 3|pages=S11-S21|date=Aug 2013|pmid=23774515|doi=10.1097/MLR.0b013e31829b1d2a|pmc=3727405}}
2. ^{{cite journal |last1=Abdullah-Koolmees |first1=Heshu |last2=Gardarsdottir |first2=Helga |last3=Yazir |first3=Dilek |last4=Stoker |first4=Lennart J. |last5=Vuyk |first5=Judith |last6=Egberts |first6=Toine C. G. |last7=Heerdink |first7=Eibert R. |title=Medication Discontinuation in Patients After Discharge From a Psychiatric Hospital |journal=Annals of Pharmacotherapy |date=9 July 2015 |volume=49 |issue=10 |pages=1085–1095 |doi=10.1177/1060028015593763}}
3. ^{{cite journal |last1=Nixon |first1=Michael |last2=Kousgaard |first2=Marius Brostrøm |title=Organising medication discontinuation: a qualitative study exploring the views of general practitioners toward discontinuing statins |journal=BMC Health Services Research |date=7 July 2016 |volume=16 |issue=1 |doi=10.1186/s12913-016-1495-2|pmc=4936268 }}
4. ^{{cite journal |last1=Linsky |first1=Amy |last2=Meterko |first2=Mark |last3=Stolzmann |first3=Kelly |last4=Simon |first4=Steven R. |title=Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing |journal=BMC Health Services Research |date=28 June 2017 |volume=17 |issue=1 |doi=10.1186/s12913-017-2391-0}}
5. ^{{cite journal |last1=Abel |first1=Julian |title=Withdrawing life-extending drugs at the end of life |journal=Prescriber |date=July 2013 |volume=24 |issue=13-16 |pages=17–20 |doi=10.1002/psb.1083}}
6. ^{{cite journal |last1=Bain |first1=Kevin T. |last2=Holmes |first2=Holly M. |last3=Beers |first3=Mark H. |last4=Maio |first4=Vittorio |last5=Handler |first5=Steven M. |last6=Pauker |first6=Stephen G. |title=Discontinuing Medications: A Novel Approach for Revising the Prescribing Stage of the Medication-Use Process |journal=Journal of the American Geriatrics Society |date=October 2008 |volume=56 |issue=10 |pages=1946–1952 |doi=10.1111/j.1532-5415.2008.01916.x}}

3 : Clinical pharmacology|Drugs|Pharmaceuticals policy

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/29 22:26:48